#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Krabbe's disease Trigeminal neuralgia Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrodysplasia ossificans progressiva Hydrocephalus Hypereosinophilic syndrome Arrhythmia Restless legs syndrome Arrhythmogenic right ventricular dysplasia Chronic lymphocytic leukaemia refractory Colorectal cancer metastatic Oesophageal adenocarcinoma Soft tissue sarcoma Antiphospholipid syndrome Henoch-Schonlein purpura nephritis More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma refractory – Basic Information Methylmalonic acidaemia – Treatment Primary hyperoxaluria – Life with Disease Osteosarcoma – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Basic Information Cholangitis sclerosing – Trials in Disease Niemann-Pick disease Toxic epidermal necrolysis – Trials in Disease Hairy cell leukaemia recurrent – Diagnostics Ornithine transcarbamoylase deficiency – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Taplucainium Chloride Metoclopramide Cemiplimab Dapagliflozin SAR444336 Everolimus ALLERGEN EXTRACTS AVTX-009 Pegunigalsidase Alfa M1P Dipotassium Salt Colistimethate Sodium Iptacopan Eculizumab MRNA-1345 Daunorubicin Inaxaplin [18F]Fluoro-Peg-Folate Istradefylline GT-002 Ibuprofen Lysine More therapies…

    Learn about Your Condition

    Haematological infection Varicella Lymphoma Marginal zone lymphoma Tetanus Pulmonary resection Factor VIII deficiency Infective uveitis Childhood asthma Measles Thyroidectomy Haemorrhage intracranial Colon cancer stage II Sickle cell disease Monogenic diabetes More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial prostatitis

  • Short-course (7‑day) versus standard 14‑day ciprofloxacin treatment for men with serious urinary tract infection

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ciprofloxacin
    Belgium

  • Study on the Effectiveness of Fosfomycin, Cefixime, and Ciprofloxacin in Treating Acute Bacterial Prostatitis in Adult Men

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacterial prostatitis
    Investigated Drugs:
    • Cefixime
    • Fosfomycin
    • Ciprofloxacin Hydrochloride
    Spain

  • Study on Fosfomycin for Treating Acute Bacterial Prostatitis in Patients with Multidrug-Resistant E. coli

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacterial prostatitis
    • Prostatitis Escherichia coli
    Investigated Drugs:
    • Fosfomycin
    Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!